Article
Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection.
Hepatology (Baltimore, Md.) - 1 Nov 2017
Désert Romain, Rohart Florian, Canal Frédéric, Sicard Marie, Desille Mireille, Renaud Stéphanie, Turlin Bruno, Bellaud Pascale, Perret Christine, Clément Bruno, Lê Cao Kim-Anh, Musso Orlando
Abstract excerpt
Hepatocellular carcinomas (HCCs) exhibit a diversity of molecular phenotypes, raising major challenges in clinical management. HCCs detected by surveillance programs at an early stage are candidates for potentially curative therapies (local ablation, resection, or transplantation). In the long term, transplantation provides the lowest recurrence rates. Treatment allocation is based on tumor number, size, vascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
